110 related articles for article (PubMed ID: 6788743)
1. Valienamine as an alpha-glucosidase inhibitor.
Kameda Y; Asano N; Yoshikawa M; Matsui K
J Antibiot (Tokyo); 1980 Dec; 33(12):1575-6. PubMed ID: 6788743
[No Abstract] [Full Text] [Related]
2. Inhibitory effect of pseudo-aminosugars on oligosaccharide glucosidases I and II and on lysosomal alpha-glucosidase from rat liver.
Takeuchi M; Kamata K; Yoshida M; Kameda Y; Matsui K
J Biochem; 1990 Jul; 108(1):42-6. PubMed ID: 2229010
[TBL] [Abstract][Full Text] [Related]
3. N-Substituted valienamines, alpha-glucosidase inhibitors.
Kameda Y; Asano N; Yoshikawa M; Matsui K; Horii S; Fukase H
J Antibiot (Tokyo); 1982 Nov; 35(11):1624-6. PubMed ID: 6761330
[No Abstract] [Full Text] [Related]
4. Enzymatic synthesis of glucoside derivatives of validamine and valienamine.
Furumoto T; Kameda Y; Matsui K
Chem Pharm Bull (Tokyo); 1992 Jul; 40(7):1871-5. PubMed ID: 1394706
[TBL] [Abstract][Full Text] [Related]
5. [Glucosidase inhibitors from Bacilli].
Schmidt DD; Frommer W; Müller L; Truscheit E
Naturwissenschaften; 1979 Nov; 66(11):584-5. PubMed ID: 390406
[No Abstract] [Full Text] [Related]
6. Synthesis and α-Glucosidase II inhibitory activity of valienamine pseudodisaccharides relevant to N-glycan biosynthesis.
Cumpstey I; Ramstadius C; Eszter Borbas K; Alonzi DS; Butters TD
Bioorg Med Chem Lett; 2011 Sep; 21(18):5219-23. PubMed ID: 21840710
[TBL] [Abstract][Full Text] [Related]
7. Nojirimycin-a potent inhibitor of purified lysosomal alpha-glucosidase from human liver.
Chambers JP; Elbein AD; Williams JC
Biochem Biophys Res Commun; 1982 Aug; 107(4):1490-6. PubMed ID: 6753846
[No Abstract] [Full Text] [Related]
8. Search for alpha-glucosidase inhibitors: new N-substituted valienamine and conduramine F-1 derivatives.
Łysek R; Schütz C; Favre S; O'Sullivan AC; Pillonel C; Krülle T; Jung PM; Clotet-Codina I; Esté JA; Vogel P
Bioorg Med Chem; 2006 Sep; 14(18):6255-82. PubMed ID: 16797996
[TBL] [Abstract][Full Text] [Related]
9. Valiolamine, a new alpha-glucosidase inhibiting aminocyclitol produced by Streptomyces hygroscopicus.
Kameda Y; Asano N; Yoshikawa M; Takeuchi M; Yamaguchi T; Matsui K; Horii S; Fukase H
J Antibiot (Tokyo); 1984 Nov; 37(11):1301-7. PubMed ID: 6392268
[TBL] [Abstract][Full Text] [Related]
10. Total asymmetric synthesis of (-)-conduramine B-1 and of its enantiomer. N-Benzyl derivatives of conduramine B-1 are beta-glucosidase inhibitors.
Łysek R; Schütz C; Vogel P
Bioorg Med Chem Lett; 2005 Jun; 15(12):3071-5. PubMed ID: 15878273
[TBL] [Abstract][Full Text] [Related]
11. Studies on the biosynthesis of the alpha-glucosidase inhibitor acarbose: valienamine, a m-C7N unit not derived from the shikimate pathway.
Degwert U; van Hülst R; Pape H; Herrold RE; Beale JM; Keller PJ; Lee JP; Floss HG
J Antibiot (Tokyo); 1987 Jun; 40(6):855-61. PubMed ID: 3301773
[TBL] [Abstract][Full Text] [Related]
12. Enzymic synthesis of valienamine glucosides and their antibiotic activity.
Furumoto T; Yoshioka T; Kamata K; Kameda Y; Matsui K
J Antibiot (Tokyo); 1991 Mar; 44(3):371-3. PubMed ID: 2026563
[No Abstract] [Full Text] [Related]
13. A new synthesis of valienamine.
Kok SH; Lee CC; Shing TK
J Org Chem; 2001 Oct; 66(21):7184-90. PubMed ID: 11597249
[No Abstract] [Full Text] [Related]
14. Properties and production of valienamine and its related analogues.
Chen X; Fan Y; Zheng Y; Shen Y
Chem Rev; 2003 May; 103(5):1955-77. PubMed ID: 12744697
[No Abstract] [Full Text] [Related]
15. Inhibition of porcine small intestinal sucrase by valienamine.
Zheng YG; Shentu XP; Shen YC
J Enzyme Inhib Med Chem; 2005 Feb; 20(1):49-53. PubMed ID: 15895684
[TBL] [Abstract][Full Text] [Related]
16. Stereoselective synthesis of a 4-⍺-glucoside of valienamine and its X-ray structure in complex with Streptomyces coelicolor GlgE1-V279S.
Si A; Jayasinghe TD; Thanvi R; Kapil S; Ronning DR; Sucheck SJ
Sci Rep; 2021 Jun; 11(1):13413. PubMed ID: 34183716
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of formation of complex oligosaccharides by the glucosidase inhibitor bromoconduritol.
Datema R; Romero PA; Legler G; Schwarz RT
Proc Natl Acad Sci U S A; 1982 Nov; 79(22):6787-91. PubMed ID: 6757922
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and alpha-D-glucosidase inhibitory activity of N-substituted valiolamine derivatives as potential oral antidiabetic agents.
Horii S; Fukase H; Matsuo T; Kameda Y; Asano N; Matsui K
J Med Chem; 1986 Jun; 29(6):1038-46. PubMed ID: 3519969
[TBL] [Abstract][Full Text] [Related]
19. Bioactive prenylated xanthones from the young fruits and flowers of Garcinia cowa.
Sriyatep T; Siridechakorn I; Maneerat W; Pansanit A; Ritthiwigrom T; Andersen RJ; Laphookhieo S
J Nat Prod; 2015 Feb; 78(2):265-71. PubMed ID: 25651042
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of an alpha-fucosidase inhibitor, 5a-carba-beta-L-fucopyranosylamine, and fucose-type alpha- and beta-DL-valienamine unsaturated derivatives.
Ogawa S; Watanabe M; Maruyama A; Hisamatsu S
Bioorg Med Chem Lett; 2002 Mar; 12(5):749-52. PubMed ID: 11858994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
